We're Horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives.
INVESTOR RELATIONS CONTACTS ; Dan Trolio Executive Vice President & CFO (860) 674-9977 dtrolio@horizontechfinance.com. ICR Group Garrett Edson Managing Director
Missing: hznp | Show results with:hznp
People also ask
Will Horizon Therapeutics be acquired?
How much did the HZNP sell for?
How much per share is Amgen paying for Horizon Therapeutics?
Who owns Horizon Pharmaceuticals?
Presentations ; 04.10.2024. Chairman and CEO Letter and Amgen Inc. 2023 Annual Report 8.1 MB ; 02.22.2024. Amgen Rare Disease Presentation 2.6 MB ; 02.06.2024. Q4 ...
... ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF ... HZNP. The Nasdaq Global Select Market. Securities ... investor is treated as a United States shareholder ...
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial ...
www.businesswire.com › news › home
Aug 8, 2023 · This earnings press release, investor deck and the related Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 are publicly ...
The Company markets 11 medicines through its orphan, rheumatology and primary care business units. Visit website. REPORT RATINGS. 4.8 / 5.0 (62). Horizon Pharma ...
... shares are admitted to trading on Nasdaq under the ticker "HZNP". ... Investor Relations, by email to ir@horizontherapeutics.com. ... financial-information/sec ...
... (HZNP) CEO Tim Walbert on Q3 2019 Results - Earnings Call Transcript · SA TranscriptsWed, Nov. 06, 2019. Horizon Pharma plc (HZNP) Investor Presentation - ...
Missing: relations | Show results with:relations
May 3, 2023 · ... HZNP) today announced first-quarter 2023 financial results. “We ... Chief Investor Relations Officer, Corporate Affairs & Chief Communications ...
Jul 17, 2023 · Investor Relations: Tina Ventura Senior Vice President, Chief Investor Relations Officer Investor-relations@horizontherapeutics.com. U.S. ...